✦ LIBER ✦

α-Galactosylceramide therapy for autoimmune diseases: prospects and obstacles

✍ Scribed by Kaer, Luc Van

Book ID: 109954880
Publisher: Nature Publishing Group
Year: 2005
Tongue: English
Weight: 327 KB
Volume: 5
Category: Article
ISSN: 1474-1741
DOI: 10.1038/nri1531

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

New prospects for autoimmune disease the

New prospects for autoimmune disease therapy: B cells on deathwatch

✍ E. William St.Clair; Thomas F. Tedder 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 211 KB 👁 2 views

Dr. St.Clair has served on the advisory boards of Genentech, Cellective Therapeutics (now owned by MedImmune), and Human Genome Sciences. Dr. Tedder has Tedder has received consulting fees (more than $10,000 per year) from Cellective Therapeutics (now owned by MedImmune), has given expert testimony

Rituximab therapy and autoimmune disorde

Rituximab therapy and autoimmune disorders: Prospects for anti–B cell therapy

✍ Gregg J. Silverman; Stuart Weisman 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 155 KB 👁 1 views

B cell–ablative therapy for the treatmen

B cell–ablative therapy for the treatment of autoimmune diseases

✍ Dhavalkumar D. Patel 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 31 KB 👁 2 views

Th22 in inflammatory and autoimmune dise

Th22 in inflammatory and autoimmune disease: prospects for therapeutic intervention

✍ Ning Zhang; Hai-Feng Pan; Dong-Qing Ye 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 170 KB

Monoclonal antibody against CD45RB for t

Monoclonal antibody against CD45RB for the therapy of rejection and autoimmune diseases

✍ R. Z. Zhong; Andrew I. Lazarovits 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 392 KB

Progress and prospects: gene therapy for

Progress and prospects: gene therapy for mitochondrial DNA disease

✍ Kyriakouli, D S; Boesch, P; Taylor, R W; Lightowlers, R N 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 160 KB